Clinical Likelihood of Sporadic Primary EGFR T790M Mutation in EGFR-Mutant Lung Cancer

Authors

Keywords

Drug resistance, Drug sensitivity, EGFR tyrosine kinase inhibitor, EGFR, mutation, Non–small-cell lung cancer, Sequencing

Journal

Volume 16, Issue 1, Pages 46-50

Publisher

Elsevier BV

Online

2014-09-29

DOI

10.1016/j.cllc.2014.09.002

Contact the author

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started